Back on December 4 I looked at the charts of Halozyme Therapeutics (HALO) , a biotechnology firm focused on novel biological and drug delivery approaches. The chart was pointed up and the indicators were bullish and I wrote that, "I have no understanding or knowledge of the company's fundamentals so you will have to do your own research. What I do know is the stock has made a good base pattern that can support further price gains, in my opinion. Trade it from the long side with a $35 sell stop."
More from Investing
Why don't more people embrace the ease and power of selling stocks? Why do they freeze and do nothing as losses build?
The hack stands to drive an uptick in corporate and government spending to protect both on-premise and cloud assets.
It doesn't take much time for stocks with strong momentum to reset and continue on their way.